Transgenomic

Such statements relate to a variety of matters, including but not limited to: the benefits and synergies expected to result from the asset acquisition; the anticipated customer base for Transgenomic following the completion of the asset acquisition; and other statements that are not purely statements of historical fact.

unknown title 2011

These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Transgenomic and are subject to significant risks and uncertainty.

unknown title 2011

Additional factors that could cause actual results to differ materially from those described in the forward-looking statements are set forth in the Annual Report on Form 10-K of Transgenomic for the year ended

unknown title 2011

All such forward-looking statements speak only as of the date they are made, and Transgenomic undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise.

unknown title 2011

She joins Transgenomic following eight years as a scientist with OSI Pharmaceuticals, where she specialized in molecular biology research and development in the area of oncology.

The Earth Times Online Newspaper 2010

Certain statements in this press release constitute "forward-looking statements" of Transgenomic within the meaning of the Private Securities Litigation Reform Act of 1995, which involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements.

The Earth Times Online Newspaper 2010

Screening test to detect autism risk in children may reach markets soon: Transgenomic Autism drug CM-AT by Curemark reaches final phase of human studies Bisphosphonates protect from toxic effects of radiation treatment, leukemia MDY-1001 polymer drug to protect intestines from radiation therapy damage from Midway Pharma

DWS Pill Scribe pillscribe 2010

Transgenomic adds DFCI's Cold-PCR mutation detection technology to its portfolio

THE MEDICAL NEWS Editors 2010

"Dr. Richardson has an impressive background and we are pleased to welcome her to Transgenomic," said Mr. Tuttle.

The Earth Times Online Newspaper 2010

All information in this press release is as of the date of the release and Transgenomic does not undertake any duty to update this information, including any forward-looking statements, unless required by law.

The Earth Times Online Newspaper 2010